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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
Primary objective
To assess the extent to which presentation to the individual of images of their own body created during medical imaging procedures
increases or decreases health behaviours such as:
1. dietary fat intake;
2. physical activity levels;
3. smoking;
4. alcohol use;
5. damaging exposure to sunlight or other sources of ultraviolet radiation.
This will be considered in comparison to the impact of communicating the same findings in a way which does not involve showing
the person the source images derived from the imaging procedure (such as solely through oral feedback, or a written report).
Secondary objective
A secondary objective is to determine the impact of this feedback on consumers’:
1. understanding of the relevant condition and of the risk information they have been given;
2. perceived severity and risk of disease;
3. perceived control over the disease risk;
4. perceived effectiveness of the risk-reducing behaviour;
5. emotional response, including general anxiety and condition-specific worry.
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B A C K G R O U N D
Achieving behaviour change is a major and perpetual challenge
in medicine and public health. To this end, there is an ongoing
interest in determiningboth the type of information and themeans
of delivery which can most powerfully motivate health behaviour
change.
Providing individuals with their clinical biomarker results (re-
sults of tests which can reveal impaired bodily function, expo-
sure to harmful substances, or susceptibility to disease) may be
one motivation method. In a 2002 review, McClure reported
that preliminary findings derived from eight trials suggested that
such biomarker feedback can motivate health behaviour change
(McClure 2002). The feedback of test results which are able to
reveal actual bodily harm (for example, structural or functional
bodily damage) attributable to a given behaviour may offer a par-
ticularly promising approach (Hirschl 2004), as the significance
of such results may be immediately comprehensible. As medical
imaging of the body (derived, for example, from ultrasound, X-
ray or Magnetic Resonance Imaging (MRI) technologies) allows
access to information which was previously unavailable and invis-
ible, clinicians are able to produce assessments of existing bodily
damage (or lack thereof ) and to classify levels of future disease
risk based on test results. Examples of applications include ultra-
sound and computed tomography to assess arterial calcification,
ultrasound to assess liver damage and radiography to assess bone
density relating to osteoporosis.
Imaging results typically require a degree of trained interpretation,
and as such they require explanation in order for recipients to
understand them. Such feedback to patients is often in the form
of oral and/or written descriptions or classifications. The source
images often remain privy to the medical staff and are not shown
to the subject of the scan. It can also be the case that the medical
images are delivered to the consumer but with little or no expla-
nation from the medical practitioner.
This review examines the addition of the acquired images them-
selves to aid in the presentation of results and motivate behaviour
change. The subject has received relatively little attention in the
literature. In essence, interventions of this type consist of the in-
dividual being shown medical images of their body together with
an explanation of what is portrayed and the implications of these
results.
There are tentative indications that such visual feedback may add
potency to risk communication. A recent Cochrane review of
biomedical risk assessment as an aid in smoking cessation (Bize
2005) found that a studywhich utilised the feedback of ultrasound
images showing the presence of arterial plaques (Bovet 2002) had
the largest effect of any of the included interventions on smoking
cessation behaviour. We are confident that there are now sufficient
studies, including several in press, to make a review of the area
viable.
Whilst diagnostic imaging is likely to be the principal focus of our
review, medical imaging is also used in a non-diagnostic capacity,
such as for educational or research purposes. Images obtained in
this context may also be used in risk communication, but the pos-
sible behavioural effects have thus far been examined with healthy
non-clinical populations. Examples include MRI to image body
composition, and ultraviolet photography to image sun-related
skin damage.
The use of diagnostic imaging is increasingly prevalent in clinical
settings (Mitka 2005). Whilst visual feedback of source images to
individuals is not generally incorporated within standard clinical
procedures at present, it is sometimes provided dependent on con-
text and case. The increasing availability of the technology offers
a corresponding potential for increased use as a motivational aid,
if research finds this to be effective.
The current review will collate the evidence concerning the be-
havioural impact of presenting images from personalised medi-
cal imaging in order to determine whether the feedback of imag-
ing findings increases risk-reducing behaviour. We will examine
the emotional and cognitive mediators and moderators of any
behavioural change, and present recommendations for future re-
search. We will also assess data on adverse events, such as anxiety
(or other unanticipated psychological effects) caused by such in-
terventions, or undesired behaviour change.
O B J E C T I V E S
Primary objective
To assess the extent to which presentation to the individual of im-
ages of their own body created during medical imaging procedures
increases or decreases health behaviours such as:
1. dietary fat intake;
2. physical activity levels;
3. smoking;
4. alcohol use;
5. damaging exposure to sunlight or other sources of ul-
traviolet radiation.
This will be considered in comparison to the impact of communi-
cating the same findings in a way which does not involve showing
the person the source images derived from the imaging procedure
(such as solely through oral feedback, or a written report).
Secondary objective
A secondary objective is to determine the impact of this feedback
on consumers’:
1. understanding of the relevant condition and of the risk
information they have been given;
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2. perceived severity and risk of disease;
3. perceived control over the disease risk;
4. perceived effectiveness of the risk-reducing behaviour;
5. emotional response, including general anxiety and con-
dition-specific worry.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials and quasi-randomised trials are eli-
gible for inclusion.
Types of participants
Clinical and non-clinical populations consisting of adult (18 years
and over) non-pregnant individuals receiving medical imaging
procedures assessing risk of disease or an existing condition (see
below), for which personal risk may be reduced by modification
of behaviour. We will also include studies of people making deci-
sions on behalf of or assisting in the potential behaviour modifica-
tion of the individual, such as family members or carers. Relevant
conditions include (but are not limited to): cardiovascular disease,
cancers, stroke, osteoporosis and diabetes.
Types of interventions
The sole or principal component of the intervention is visual feed-
back of an individual’s medical imaging results. Visual feedback
is defined as the individual being shown source images (still or
moving images) of their body generated by the procedure in the
course of the communication of their results. Typically we would
expect this to consist of the individual being shown a medical im-
age of their body (such as a scan image of arterial plaque) and
being talked through the details of what the image portrays and
the implications this has for their health and behaviour (in this ex-
ample, outlining the role of health behaviour in determining their
vascular health). We will exclude interventions which use library
images or images of other people’s scans only (rather than images
of the individual themselves) as the focus of risk communication.
We will include complex multiple-component interventions in
which individual visual feedback is one of an array of interven-
tions, on the condition that an effect-size can be ascertained for
the individual visual feedback intervention component. We will
present a separate table of studies which havemultiple-component
interventions including individual visual feedback, which are in-
eligible for inclusion.
For clarification, medical imaging is defined as the MeSH defini-
tion for diagnostic imaging, but applied without the considera-
tion of diagnostic intent: “any visual display of structural or func-
tional patterns of organs or tissues” (MeSH 2008). The specific
procedures which are encompassed under this definition, in line
with MeSH organisation, include magnetic resonance imaging,
tomography, radiography and ultrasonography.
Acceptable comparison groups are those that provide:
1. no risk information at all;
2. risk information derived from a non-medical imaging
method (e.g. cholesterol test); or
3. personalised health-related risk information derived
from medical imaging procedures but presented to the
individual without visual feedback.
We will exclude studies which use imagined scenarios and risk
information.
Types of outcome measures
Included trials must report a behavioural outcome or report the
intention to engage in risk-reducing behaviour. All outcomes may
be measured either objectively or subjectively.
Primary outcomes (behavioural endpoints)
Engagement in health-related behaviours that have the potential
to modify the risk identified, such as:
• Dietary behaviour;
• Physical activity;
• Weight control;
• Smoking;
• Alcohol consumption;
• Attendance for screening;
• Sun protection behaviours;
• Adherence to medication;
• Use of drugs of abuse.
Secondary outcomes
Intention to engage in health-related behaviours that have the
potential to modify the risk identified, such as:
• Dietary behaviour;
• Physical activity;
• Weight control;
• Smoking;
• Alcohol consumption;
• Attendance for screening;
• Sun protection behaviours;
• Adherence to medication;
• Use of drugs of abuse.
Cognitive and emotional mediators and moderators including:
• Understanding of the relevant condition and of the risk
information they have been given;
• Perceived severity and risk of disease;
• Perceived control over the disease risk;
• Perceived effectiveness of the risk-reducing behaviour;
• Emotional response, including general anxiety and con-
dition-specific worry;
• Acceptability of the intervention.
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Physical/health status outcomes, such as:
• Blood pressure;
• Cholesterol level;
• Lung function;
• Weight;
• Level of atherosclerosis.
Costs associated with featured interventions.
Adverse events
Any adverse events that are reported in the included trials will be
noted. These might include clinical levels of depression or anxiety.
Search methods for identification of studies
Electronic searches
Electronic searches
We will search the following databases:
• Cochrane Central Register of Controlled Trials (CEN-
TRAL, The Cochrane Library),
• CINAHL (1982 to present),
• MEDLINE (1950 to present),
• EMBASE (1980 to present)
• PsycINFO (1985 to present).
The search strategies were developed to comprise searches both for
keywords and medical subject headings under existing database
organisational schemes. They aimed to identify articles reporting
on randomised controlled trials that comprised both a disease risk
assessment involving medical imaging feedback and a measure of
the effect on behaviour. The strategy for MEDLINE (Ovid SP) is
presented at Appendix 1.
We will search the ProQuest Dissertations and Theses database
for grey literature.
We will search databases in the metaRegister of Randomised Con-
trolled Trials to identify ongoing studies. If applicable, we will
present relevant ongoing studies in a table in the review.
Searching other resources
We will attempt to contact authors of all included studies (along
with other key researchers in the field) to identify other studies, and
to ascertain further details of methodology and data of included
studies.
We will search reference lists of relevant studies and systematic
reviews. We will not handsearch journals.
Data collection and analysis
Selection of studies
Two review authors will pre-screen all search results (titles and
abstracts) for possible inclusion, and those selected by either or
both authors will be subject to full-text assessment. Two review
authors will independently assess the selected articles for inclusion.
Any discrepancies will be resolved by consensus, overseen by a
third author acting as arbiter, with approval by one review author
and the arbiter being sufficient. We will list those studies excluded
after full-text assessment in the table ’Characteristics of Excluded
Studies’, giving reasons for exclusion.
Data extraction and management
We will develop a data extraction form based on the Cochrane
Consumers and Communication Review Group’s template, and
pilot and amend it as necessary.We will extract the following main
sets of data from each included study:
• lead author; date;
• study participant inclusion criteria;
• participants (participant diagnoses/condition(s) andde-
mographics: race/ethnicity, gender, religion/culture, so-
cioeconomic status, age);
• study design and timetable; randomisation; allocation
concealment;
• interventions (content and format of interventions, in-
cluding details of oral information or description pro-
vided; nature of results given toparticipants; actual diag-
nostic result; intervention setting and delivery provider;
delivery of any co-interventions, theoretical basis of in-
tervention if stated);
• numbers of participants in each trial arm;
• outcome measures; time(s) at which outcomes assessed;
• results;
• confounders;
• analysis;
• additional comments.
At least two authors will independently extract data to the data
extraction form. The forms will then be checked by a third author
and any errors or inconsistencies resolved. The first author will
enter the data into RevMan, with another author checking the
accuracy of data entry .
Assessment of risk of bias in included studies
We will assess and report on the risk of bias of included studies
in accordance with the guidelines in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2008), which rec-
ommends the explicit reporting of the following individual do-
mains:
• Sequence generation;
• Allocation concealment;
• Blinding of participants, personnel and outcome asses-
sors (assessed for each main outcome or class of out-
come);
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• Incomplete outcome data (assessed for each main out-
come or class of outcome);
• Selective outcome reporting;
• Other sources of bias.
We will also examine and report the following:
• Validation and reliability of outcome measures;
• Whether the study obtained ethics committee approval
and ensured informed consent for participation;
• Use of standardised protocols for information delivery.
We will check for consistency of the delivery of inter-
ventions where possible.
Two review authors will independently assess the risk of bias in
included studies, with any disagreements resolved by discussion
and consensus, and with a third author acting as arbiter. We will
present our assessment in risk of bias tables for each included study.
We will contact study authors for additional information about
the study methods as necessary. We will incorporate the results
of the risk of bias assessment into the review through narrative
description and commentary about each of the items mentioned.
This will lead to an overall assessment of the risk of bias of the
included studies (Ryan 2007).
Measures of treatment effect
We will analyse separately measures of motivation to engage in
behaviour, and measures of actual behaviour. The nature of the
measures used (for example, the content of questionnaire items or
the objective instruments utilised) within each type of behavioural
outcome may differ, but where regarded as comparable will be in-
tegrated and standardised to have common effect sizes. Effect size
for continuous outcome measures will be defined as the standard-
ised mean difference (SMD), with the effect size for binary out-
comes being the odds ratio (OR). We will convert all effect sizes
to OR for comparison. We will obtain a pooled effect size with
95% confidence interval (CI) using the random-effects model.
Dealing with missing data
Wewill conduct intention-to-treat analyses accounting formissing
data where possible, and when this is not possible will analyse
results as reported. For smoking cessation outcomes we will follow
the principle that missing data is usually regarded as continued
smoking. We will report on levels of drop outs in the intervention
and comparison groups as an indicator of ’acceptability’ of the
intervention, and the likelihood of bias.
Assessment of heterogeneity
We will test for heterogeneity using the Chi2 test and further
quantify any heterogeneity using the I2 statistic (which describes
the percentage of the variability in effect estimates that is due to
heterogeneity rather than sampling error). A value greater than
50% will be considered to represent substantial heterogeneity (
Higgins 2003; Higgins 2008). We will investigate heterogeneity
by assessing any contribution from outliers.
We will assess for publication bias using funnel plots to informally
examine any relationship between study quality and effect size (
Sutton 2000).
Data synthesis
We will conduct a narrative synthesis of the included studies, di-
viding them into clinical and non-clinical categories. Within these
categories we will present studies’ major characteristics and re-
sults. If the studies are sufficiently similar in terms of population,
inclusion criteria, interventions and/or outcomes (including the
time(s) at which these are assessed), we will consider pooling the
data statistically using meta-analysis.
Fixed-effect models assume that exactly the same population effect
size is obtained for all studies in the meta-analysis, while random-
effects models allow for the possibility that population parameters
vary from study to study. We have opted for a random-effects
model, reflecting the heterogeneity likely to arise from the use of
different settings, participant groups, disease areas, interventions
and measures across the studies.
Subgroup analysis and investigation of heterogeneity
The included studies are likely to be heterogeneous in terms of the
health condition being imaged, and the behaviours that could re-
duce health risks. We will consider this heterogeneity when evalu-
ating the review’s results, but will not undertake a formal subgroup
analysis - due both to the likelihood of insufficient studies being
found, and the lack of a clear clinical or theoretical imperative for
such analysis.
Sensitivity analysis
We will remove the lower quality studies (median split based on
aggregate risk of bias rating) from the analysis to check the robust-
ness of the results. We will undertake further sensitivity analysis to
examine the impact of missing data, comparing results following
intention-to-treat analysis to data actually found.
Consumer input
The protocol and review will be peer reviewed by at least one con-
sumer, as part of the Cochrane Consumer and Communication
Review Group’s standard editorial process. We will seek additional
feedback from members of the Cochrane Consumer Network at
draft review stage.
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A P P E N D I C E S
Appendix 1. MEDLINE (Ovid SP) search strategy
1. exp diagnostic imaging/
2. diagnosis computer assisted/
3. (mri or magnetic resonance imaging or microscop* or photograph* or holograph* or radiograph* or spectroscop* or stroboscop* or
subtraction technique* or thermograph* or tomograph* or transilluminat* or ultrasonograph* or ultrasound or imaging or scan*).tw.
4. 1 or 2 or 3
5. ((show* or presented or presenting or presentation or display* or given or giving or gave or receiv* or provided or providing or
provision or view* or expos* or intervention* or motivat* or inform*) adj7 (image* or imaging or picture* or depict* or recording*
or scan* or photo or photograph* or radiograph* or tomograph* or thermograph* or holograph* or ultrasound or ultrasonograph* or
visual* or their or result*)).tw.
6. (visual* adj10 feedback).tw.
7. 5 or 6
8. 4 and 7
9. (adher* or complian* or noncomplian* or motivat*).tw.
10. patient compliance/
11. health behavior/
12. health knowledge attitudes practice/
13. risk reduction behavior/
14. attitude to health/
15. motivation/ or intention/
16. patient education as topic/
17. counseling/ or directive counseling/
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18. or/9-17
19. 8 and 18
20. randomized controlled trial.pt.
21. controlled clinical trial.pt.
22. randomized.ab.
23. placebo.ab.
24. drug therapy.fs.
25. randomly.ab.
26. trial.ab.
27. groups.ab.
28. or/20-27
29. humans.sh.
30. 28 and 29
31. 19 and 30
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